NCT06647511

Brief Summary

The goal of this observational study is to use digital health tracking to improve how high blood pressure and other health issues are detected in pregnant refugee women. The main questions this study aims to answer are are:

  • Can a digital monitoring system that checks for high blood pressure in these women be tested and refined, using clinical training and validation?
  • Can this digital monitoring system accurately track any related pregnancy health issues and be used to refer participants to care providers?
  • Can this system be used to accurately identify risks associated with the contraction of pregnancy-related conditions, such as preeclampsia and high blood pressure? Participants will:
  • Complete baseline and follow-up in-person appointments;
  • Complete surveys at these appointment that track their health, stress levels, and comorbidities/risks associated with pregnancy;
  • Be given a smartwatch fitness tracker and electronic blood pressure cuffs for at-home measurements.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
75

participants targeted

Target at P50-P75 for all trials

Timeline
27mo left

Started Sep 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Sep 2024Sep 2028

Study Start

First participant enrolled

September 12, 2024

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

October 15, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 17, 2024

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

4 years

First QC Date

October 15, 2024

Last Update Submit

April 20, 2026

Conditions

Keywords

refugeepregnantdigital

Outcome Measures

Primary Outcomes (1)

  • Digital Sensitivity for detecting gestational hypertension (HTN)

    The diagnostic accuracy of the digital blood pressure cuffs will be compared to the measurements taken during in-person visits.

    13 months [maximum duration of enrollment]

Secondary Outcomes (20)

  • Number of Participants that Complete All Surveys Between Appointments

    13 months [maximum duration of enrollment]

  • Number of Participants That Complete All Surveys at the Baseline Appointment

    13 months [maximum duration of enrollment]

  • Number of Participants Referred to Physicians/Care that do not have a designated provider

    13 months [maximum duration of enrollment]

  • Number of Participants With No Comorbid Pain as Assessed by BPI-SF

    13 months [maximum duration of enrollment]

  • Number of Participants With Mild Comorbid Pain as Assessed by BPI-SF

    13 months [maximum duration of enrollment]

  • +15 more secondary outcomes

Study Arms (1)

Pregnant Refugees

Participants will complete validated questionnaires, regular blood pressure measurements, pain and trauma assessments, and clinical monitoring during this study.

Device: Nokia-Withings BPM Connect Blood Pressure MonitorDevice: Smartwatch Devices

Interventions

Passive continuous collection of digital data (e.g., daily heart rate trends, activity levels, sleep measurements) for exploratory outcomes will occur via Apple Watches and Fitbit Versa 3s, which are synced to a smartphone application.

Pregnant Refugees

At-home blood pressure (BP) measurements will be weekly via a blood pressure cuff (e.g., Nokia-Withings BPM (Beats per Minute) Connect), with measurements being manually entered into the study specific smartphone app.

Pregnant Refugees

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population is a pregnant refugee, or asylee as designated by the U.S. Government.

You may qualify if:

  • Pregnant
  • Refugee, asylum seeking, or asylee as designated by the U.S. Government
  • Greater than or equal to 18 years of age
  • Has a personal smartphone

You may not qualify if:

  • Unable to provide informed consent
  • Determined by the PI to be in an extremely vulnerable position and therefore not suited for research participation
  • Planned move from the New York City (NYC) area within the next 24 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medicine

New York, New York, 10065, United States

RECRUITING

MeSH Terms

Conditions

Hypertension, Pregnancy-Induced

Condition Hierarchy (Ancestors)

Pregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Study Officials

  • Gunisha Kaur, MA, MD

    Weill Medical College of Cornell University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Gunisha Kaur, MA, MD

CONTACT

Michele Steinkamp, RN

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2024

First Posted

October 17, 2024

Study Start

September 12, 2024

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 1, 2028

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations